David R. Byrd

1995–2022 年に発表

48
論文数
23,981
被引用数
46
h 指数
48
i10 指数

被引用数

David R. Byrd の年別被引用数1996 年: 被引用 3 件1997 年: 被引用 4 件1998 年: 被引用 8 件1999 年: 被引用 15 件2000 年: 被引用 23 件2001 年: 被引用 50 件2002 年: 被引用 80 件2003 年: 被引用 77 件2004 年: 被引用 68 件2005 年: 被引用 68 件2006 年: 被引用 75 件2007 年: 被引用 66 件2008 年: 被引用 66 件2009 年: 被引用 76 件2010 年: 被引用 80 件2011 年: 被引用 148 件2012 年: 被引用 170 件2013 年: 被引用 161 件2014 年: 被引用 152 件2015 年: 被引用 132 件2016 年: 被引用 113 件2017 年: 被引用 139 件2018 年: 被引用 155 件2019 年: 被引用 623 件2020 年: 被引用 866 件2021 年: 被引用 752 件2022 年: 被引用 516 件2023 年: 被引用 420 件2024 年: 被引用 785 件2025 年: 被引用 265 件2026 年: 被引用 13 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,480 件、この内訳の 25.1%中国: 引用元論文 1,061 件、この内訳の 10.7%イタリア: 引用元論文 687 件、この内訳の 6.9%ドイツ: 引用元論文 539 件、この内訳の 5.5%イギリス: 引用元論文 519 件、この内訳の 5.2%オーストラリア: 引用元論文 436 件、この内訳の 4.4%フランス: 引用元論文 389 件、この内訳の 3.9%オランダ: 引用元論文 386 件、この内訳の 3.9%カナダ: 引用元論文 299 件、この内訳の 3%スペイン: 引用元論文 253 件、この内訳の 2.6%日本: 引用元論文 231 件、この内訳の 2.3%スイス: 引用元論文 186 件、この内訳の 1.9%
0%25.1%その他 24.6%

分野

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology4.4%
  • Computer Science1.3%
  • Engineering1.1%
  • Health Professions0.2%
  • その他1.7%

トピック

  • Cutaneous Melanoma Detection and Management7.5%
  • Melanoma and MAPK Pathways4.1%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Immunotherapy and Immune Responses3.6%
  • Nonmelanoma Skin Cancer Studies3.1%
  • CAR-T cell therapy research2.1%
  • その他75.7%

共著者

全論文

検索で開く
  1. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

    著者: , , , , , , , , , - CA A Cancer Journal for Clinicians 2017 被引用: 6,520

  2. Final Version of 2009 AJCC Melanoma Staging and Classification

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 4,570

  3. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 被引用: 144

  4. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 被引用: 1,385

  5. The TNM classification of malignant tumours—towards common understanding and reasonable expectations

    著者: , , , , , , , , , - The Lancet Oncology 2017 被引用: 286

  6. Age-Specific Incidence of Melanoma in the United States

    著者: , , , , , , , , , , - JAMA Dermatology 2019 被引用: 224

  7. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 被引用: 2,401

  8. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , K Hoffmann, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2018 被引用: 370

  9. Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 92

  10. Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma

    著者: , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 132

  11. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Turcotte, Cecilia C.S. Yeung, Howard L. Kaufman - Journal for ImmunoTherapy of Cancer 2020 被引用: 33

  12. Thyroid Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2010 被引用: 205

  13. Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 359

  14. Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 296

  15. Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2011 被引用: 147

  16. Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

    著者: , , , , , , , - Annals of Surgery 2017 被引用: 83

  17. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey D. Wayne, Heather B. Neuman, B. Mark Smithers, Charlotte E. Ariyan, Darius C. Desai, Jeffrey E. Gershenwald, Shlomo Schneebaum, Anja Gesierich, Lisa K. Jacobs, James M. Lewis, Kelly M. McMasters, Christina O’Donoghue, André van der Westhuizen, Armando Sardi, Richard J. Barth, Robert M. Barone, Jonathan McKinnon, Craig L. Slingluff, Jeffrey M. Farma, Erwin Schultz, Randall P. Scheri, Sergi Vidal‐Sicart, Manuel Alberto Molina, Alessandro Testori, Leland J. Foshag, Lisa Van Kreuningen, He-Jing Wang, Myung‐Shin Sim, Richard A. Scolyer, David Elashoff, Alistair J. Cochran, Mark B. Faries - JAMA Surgery 2022 被引用: 44

  18. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base

    著者: , , , , , , , , , - JNCI Journal of the National Cancer Institute 2016 被引用: 228

  19. Pulsed radiofrequency for chronic pain

    著者: , - Current Pain and Headache Reports 2008 被引用: 226

  20. Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2014 被引用: 156

  21. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy

    著者: , , , , , , , , , , - Supportive Care in Cancer 2018 被引用: 87

  22. Global Consultation on Cancer Staging: promoting consistent understanding and use

    著者: , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2019 被引用: 85

  23. Current and future cancer staging after neoadjuvant treatment for solid tumors

    著者: , , , , - CA A Cancer Journal for Clinicians 2020 被引用: 75

  24. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    著者: , , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2010 被引用: 555